Diagnostic innovation, using infrared spectroscopy to analyse samples for markers of disease across a wide range of conditions.

Glyconics Ltd is aiming to develop an innovative approach to the diagnosis and monitoring of chronic and acute diseases including respiratory disease.

The Company is seeking to develop a new hand-held miniaturised device to aim to effectively diagnose and predict the exacerbation of Chronic Obstructive Pulmonary Disease (COPD) in patients at the point of care.  The Company’s aim is to optimise the hand-held, miniaturised device for easy detection of disease monitoring by healthcare workers at the point-of-care.

  • Product

    Life Sciences SEIS
  • Sector

  • Status

  • HMRC

    Advanced Assurance